Big Pharma spend less than a fifth of their revenues in America on R&D, but over a third peddling pills.
Raymond Hill, of IMS Health, a consultancy, says that firms too often “differentiate pills using sales reps” rather than by superior innovation.
Source
No comments:
Post a Comment